TY - JOUR
T1 - Rectal cancer, version 6.2020
T2 - Featured updates to the NCCN guidelines
AU - Benson, Al B.
AU - Venook, Alan P.
AU - Al-Hawary, Mahmoud M.
AU - Arain, Mustafa A.
AU - Chen, Yi Jen
AU - Ciombor, Kristen K.
AU - Cohen, Stacey
AU - Cooper, Harry S.
AU - Deming, Dustin
AU - Garrido-Laguna, Ignacio
AU - Grem, Jean L.
AU - Gunn, Andrew
AU - Hoffe, Sarah
AU - Hubbard, Joleen
AU - Hunt, Steven
AU - Kirilcuk, Natalie
AU - Krishnamurthi, Smitha
AU - Messersmith, Wells A.
AU - Meyerhardt, Jeffrey
AU - Miller, Eric D.
AU - Mulcahy, Mary F.
AU - Nurkin, Steven
AU - Overman, Michael J.
AU - Parikh, Aparna
AU - Patel, Hitendra
AU - Pedersen, Katrina
AU - Saltz, Leonard
AU - Schneider, Charles
AU - Shibata, David
AU - Skibber, John M.
AU - Sofocleous, Constantinos T.
AU - Stoffel, Elena M.
AU - Stotsky-Himelfarb, Eden
AU - Willett, Christopher G.
AU - Johnson-Chilla, Alyse
AU - Gurski, Lisa A.
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2020.
PY - 2020/7
Y1 - 2020/7
N2 - The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines. These updates include clarifying the definition of rectum and differentiating the rectumfromthe sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer, with a focus on new treatment options for patients with BRAF V600E- or HER2 amplification- positive disease.
AB - The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines. These updates include clarifying the definition of rectum and differentiating the rectumfromthe sigmoid colon; the total neoadjuvant therapy approach for localized rectal cancer; and biomarker-targeted therapy for metastatic colorectal cancer, with a focus on new treatment options for patients with BRAF V600E- or HER2 amplification- positive disease.
KW - Colonic Neoplasms/diagnosis
KW - Humans
KW - Neoadjuvant Therapy
KW - Practice Guidelines as Topic
KW - Rectal Neoplasms/diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85087689875&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000577820100003&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.6004/jnccn.2020.0032
DO - 10.6004/jnccn.2020.0032
M3 - Review article
C2 - 32634771
SN - 1540-1405
VL - 18
SP - 807
EP - 815
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 7
ER -